biomesight.com

What It Is

Biomesight is a gut microbiome testing and analytics platform registered in England. It sells test kits directly to consumers, while also offering API, white-label, and data analytics capabilities for health tech companies, nutrition apps, telemedicine providers, corporate wellness programs, clinics, and research institutions. Its core business is not a traditional off-the-shelf ecommerce model, but a health-commerce service chain built around testing kits, reports, and supplement recommendations.

Core Capabilities and Fulfillment

The platform uses 16S rRNA V4 region sequencing. Its reports include 43 Gut Health Scores, cover up to 3,000 microbial species, and provide insights across areas such as probiotics, commensal bacteria, potential pathogens, short-chain fatty acid producers, vitamin synthesis, and lactose/oxalate intolerance. After placing an order, users receive a sampling kit, send the sample back, and view results in the App. The official turnaround time is 2-4 weeks. The Partner API supports order creation, kit registration, JSON/PDF/CSV result retrieval, order and sample status lookup, and Webhook-based status updates, making it suitable for embedded ecommerce and health platform integrations.

Pricing and Fees

Public pricing shows consumer kits from £89 and researcher kits from £60. Practitioner and researcher accounts are $0/month, and the academic research FASTQ upload service is free. The site mentions affiliates, resellers & distributors, and discounted kits, but does not disclose commission rates, wholesale pricing tiers, or settlement rules. Payment methods were also not found in the crawled text.

Pros and Cons

The main advantage is its relatively open data access: it supports FASTQ and CSV downloads, as well as FASTQ uploads from other labs such as Ombrelab, Psomagen, and Olawell. Cohort Selector and Cohort Analyzer are valuable for researchers. Supplement recommendations can match against 20,000+ products, which may help drive downstream conversions. The limitations are that Biomesight states it is not intended to diagnose, treat, cure, or prevent disease, and the text around Amazon FBA fulfillment integration suggests it has not yet been fully implemented. Details on supported shipping countries, payments, after-sales support, and compliance are also insufficient.

Who It Is For and Access from China

Biomesight is better suited to health management platforms, nutritionists, clinics, telemedicine providers, corporate wellness programs, white-label partners, and research institutions. It is not a good fit for ordinary sellers who only want to run a generic cross-border catalog ecommerce business. Access from China is not specified in the available text, so it should be considered unknown; payment methods are also unclear. Alternatives are not listed here because the source text does not provide any.